基于伊米达佐[2,1-b]醇的胺-2,3-二氧化酶1 (IDO1) 抑制剂:基于结构的设计,合成,生物评估和对接研究
Rahul Singh1, Ravinder Kumar1, Ashalata Roy2
1Department of Chemistry and Centre of Advanced Studies in Chemistry, Panjab University, Chandigarh 160014, India.
Bioorganic & medicinal chemistry letters
|October 22, 2023
概括
研究人员设计了新型的化异环化合物,作为潜在的甲胺-2,3-二氧化酶1 (IDO1) 抑制剂. 这些化合物显示出有希望的IDO1抑制活性,并且无毒,为IDO1相关疾病提供了新的治疗策略.
科学领域:
- 药用化学 医学化学
- 酶学 是一种酶学.
- 药物发现 药物发现 药物发现
背景情况:
- 胺二,3-二氧化酶1 (IDO1) 是 Tryptophan代谢中的一个关键酶,涉及免疫抑制和癌症和疟疾等疾病的进展.
- 过度表达IDO1有助于各种危及生命的疾病,推动了有效治疗干预的需要.
- IDO1的联结口袋为开发向抑制剂提供了机会.
研究的目的:
- 设计和合成新型化异环化合物作为人类IDO1.1.的潜在抑制剂.
- 评估合成化合物的体外抑制活性和细胞毒性.
- 通过分子对接,研究这些化合物在IDO1活性部位内的结合相互作用.
主要方法:
- 基于结构的药物设计,利用人类的X射线晶体结构 IDO1.1.
- 新型化异环基基架的化学合成.
- 在体外酶分析以确定IDO1抑制活性 (IC50值).
- 使用HEK293细胞进行细胞活力测定,以评估化合物毒性.
- 分子对接研究来分析联体酶相互作用.
主要成果:
- 两个合成的化合物,标记为30和41,表现出显著的人类IDO1抑制活性,IC50值分别为23μM和13μM.
- 鉴定到的被击中化合物在100μM的度下被发现对HEK293细胞无毒.
- 接研究表明,合成的抑制剂与IDO1活性部位相互作用,其方向与已知的共同结晶的配体相似.
结论:
- 新型化异环化合物成功设计,合成,并被确定为人类IDO1.1的强有力的抑制剂.
- 合成的化合物具有良好的安全性,在有效度下是无毒的.
- 这些发现支持这些新型支架的潜力,以进一步发展为针对IDO1介导疾病的治疗剂.
关键词:
3-二氧化基酶的使用方法这是一种IDO1抑制剂.伊米达佐 (Imidazo) [2,1-b] 亚 (thiazole) 是一种亚的化合物.伊米达 (Imidazole) 是一种药物.印度醇胺-2 的含量.一-三甲是什么?更多相关视频
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
1.2K
14:11Synthesis of pH Dependent Pyrazole, Imidazole, and Isoindolone Dipyrrinone Fluorophores using a Claisen-Schmidt Condensation Approach
Published on: June 10, 2021
6.2K
相关概念视频
Structure-Activity Relationships and Drug Design
735
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
735
Drug Discovery: Overview
8.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.0K
Induced-fit Model
81.0K
Most chemical reactions in cells require enzymes—biological catalysts that speed up the reaction without being consumed or permanently changed. They reduce the activation energy needed to convert the reactants into products. Enzymes are proteins, that usually work by binding to a substrate—a reactant molecule that they act upon.
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...
81.0K
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
3.0K
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the...
3.0K
